China’s HaiHe Biopharma raises $146.6 mln led by Huagai Capital

02/13/2019 9:33:00 AM (GMT)

Chinese pharmaceutical company HaiHe Biopharma has raised $146.6 million in a financing round.

HaiHe Biopharma plans to use the funds to advance research and development push into its innovative anti-cancer drugs in clinical and pre-clinical stages.

The financing round was led by Chinese private equity investment firm Huagai Capital.

Other backers that participated in the round included Yingke PE, CSPC Pharmaceutical, Hillhouse Capital, Chinese Academy of Sciences Venture Capital, Atlas Capital, Boyuan Capital, Elite Capital, and Daehwa Pharmaceutical.

Haihe Biopharma Co. Ltd.

All success stories are prepared by Investsize editors which is selecting elite and remarkable information from press releases and anonymous news sources.There is no charge applied for any success stories which is published . Those published success stories are not investment advices and doesnt offer recommendations Alternate Text